D-[3H]Glucosamine Labelling of Epidermal and Dermal Glycosaminoglycans in Cultured Human Skin
- 31 December 1987
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 26 (3) , 123-134
- https://doi.org/10.1515/cclm.1988.26.3.123
Abstract
An in vitro model is presented for the study of glycosaminoglycans in human skin. The synthesis of six glycosaminoglycan species in both dermis and epidermis was measured by D-[3H]glucosamine labelling. Punched biopsies (epidermis + entire dermis) of 3 mm in diameter were cultured at 37.degree. C in 5% carbon dioxide-95% air. When the label was added 18 h after explanation, the incorporation started immediately, and for all glycosaminoglycans the time-dependent incorporation was linear for 16 h. The experimental variation was minimized by expressing the measurments in epidermis "per explant" and in dermis "per mg of wet explant". A ratio to dermal hydroxyproline did not improve the precision. Most of the variation arose "before" isolation and separation of the glycosaminoglycans. The labelled products were macromolecules and were converted to small molecules by chondroitinase ABC + heparinase. The total incorporation in dermis was 2 1/2 times higher than in epidermis. Hyaluronic acid was the predominant synthesized product in dermis, and hyaluronic acid and heparan sulphate were the predominant products in epidermis. The proportions (%) in dermis/epidermis were as follows: hyaluronic acid, 61/44; heparan sulphate, 18/31; dermatan sulphate, 5/8; chondroitin 4/6-sulphate, 10/7 and heparin-like glycosaminoglycan, 1/2. The same species were also demonstrated as native constituents of uncultured human skin. Hyaluronic acid and dermatan sulphate predominated in dermis, whereas no single species predominated in epidermis. Their concentrations in uronic acid equivalents per mg of wet skin (pmol/mg of epidermis + dermis) were as follows in dermis/epidermis: hyaluronic acid, 243/0.48; heparan sulphate, 22/0.44; dermatan sulphate, 170/0.56; chondroitin 4/6-sulphate, 72/0.50; and heparin-like glycosaminoglycan, 5/0.22. Thus, only 0.4% of the in vivo synthesized glycosaminoglycan was present in epidermis.This publication has 10 references indexed in Scilit:
- Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growthThe Journal of cell biology, 1981
- Characterization of epidermal glycosaminoglycans synthesized in organ cultureBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies.Circulation Research, 1980
- The dermis is required for the synthesis of extracellular glycosaminoglycans in cultured pig epidermisBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- COMPARATIVE-STUDY OF EXTRACELLULAR SULFATED GLYCOSAMINOGLYCANS SYNTHESIZED BY RABBIT CORNEAL FIBROBLASTS IN ORGAN AND CONFLUENT CULTURES1976
- Factors regulating the keratan sulphate biosynthesis in bovine corneaExperimental Eye Research, 1972
- Influence of corneal epithelium on the incorporation of 35SO4 into stromal glycosaminoglycansExperimental Eye Research, 1971
- Structure of dermatan sulfateBiochimica et Biophysica Acta (BBA) - General Subjects, 1968